Novocure (Nasdaq:NVCR) announced that the FDA granted approval for its Optune Pax treatment for advanced pancreatic cancer.

There are some languages that don't need mass appeal to be loved. Elixir, Lua, Zig, Clojure, Julia, and Rust prove that point ...

Just-In-Time Compiler for the Lua Programming language. Fork of LuaJIT to continue development. This project does not have an active maintainer, see https://twitter ...

With four FDA-approved oncology indications and trials exploring new uses, tumor treating fields are emerging as a promising therapeutic option for certain patients with cancer. While using ...

Cynthia Erivo and Ariana Grande return to Oz for the second part of Jon M. Chu’s maximalist adaptation of the Broadway musical. By Manohla Dargis When you purchase a ticket for an independently ...

Football legend Tom Brady shared on Tuesday that his dog Junie is a clone of his former pooch, Lua, who died in 2023. The brown pit bull mix was cloned using a blood sample collected before Lua’s ...

Security researchers at Wiz Research have discovered a critical vulnerability in the Redis in-memory database that could allow an attacker to gain remote code execution (RCE) capabilities and take ...

Welcome to the Fentanyl.lua repository! This project aims to provide a powerful debugging tool for Roblox developers and users. Whether you're troubleshooting scripts or exploring new features, ...

A 13-year-old vulnerability that affects all versions of the Redis open source data storage service can allow attackers to take full control of a host system, posing a significant threat to cloud ...

A critical-severity vulnerability that lingered in Redis for 13 years potentially exposes 60,000 servers to exploitation, cybersecurity firm Wiz warns. Redis is an open source platform that stores ...

NASA on Monday introduced the 10 people — selected from a pool of 8,000 applicants — who will join the agency’s astronaut corps as it races to return to the moon before attempting an unprecedented ...

(RTTNews) - Novocure (NVCR) announced that Japan's Ministry of Health, Labour and Welfare approved Optune Lua for concurrent use with PD-1/PD-L1 inhibitors for the treatment of adult patients with ...